Overview

Evaluation of Dentin Hypersensitivity Using Glass Ionomer Cements

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The aim of this randomized, double-blind, split-mouth clinical trial is to evaluate and compare the desensitizing efficacies of the resin-modified glass ionomer cement ClinproTM XT (3M ESPE, Minnesota, USA) and the conventional glass ionomer cement Vidrion R (SS White, Gloucester, UK) at 2-year follow-up.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Federal University of Pelotas
Treatments:
Methamphetamine